Syros Pharmaceuticals Inc (SYRS)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0242 -0.0008 (-3.20%) 15:59 ET [OTC US]
N/A x N/A N/A x N/A
Post-market - - (-) 15:59 ET
for Thu, Apr 3rd, 2025
Results
download Want to compare other data? Select Fields| Symbol | SYRS | EVAX | EYEN | ||
| Company | Syros Pharmaceuticals Inc | Evaxion Biotech A/S ADR | Eyenovia Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.0250 | 1.6200 | 1.1500 | ||
| High | 0.0250 | 1.6900 | 1.1700 | ||
| Low | 0.0208 | 1.5500 | 1.0912 | ||
| Last | 0.0242 | 1.6900 | 1.1100 | ||
| Change | -0.0008 | unch | -0.0700 | ||
| % Change | -3.20% | unch | -5.93% | ||
| Volume | 206,357 | 31,952 | 25,423 | ||
| 20-Day Average Volume | N/A | 64,573 | 496,174 | ||
| Previous Close | 0.0250 | 1.6900 | 1.1800 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | N/A | 1.8099 | 1.4151 | ||
| 20-Day Raw Stochastic | N/A | 31.91% | 7.86% | ||
| 20-Day Relative Strength | N/A | 37.09% | 30.20% | ||
| Weighted Alpha | N/A | -85.80 | -90.78 | ||
| Today's Opinion | N/A | 100% Sell | 100% Sell | ||
| Previous Opinion | N/A | 100% Sell | 100% Sell | ||
| Last Month's Opinion | N/A | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -20.39% since 03/27/25 | -3.98% since 03/27/25 | -11.78% since 03/27/25 | ||
| Low | 0.0207 on 04/02/25 | 1.5500 on 04/03/25 | 1.0563 on 03/31/25 | ||
| High | 0.0309 on 03/31/25 | 1.8600 on 04/01/25 | 1.2600 on 03/28/25 | ||
| 1-Month | |||||
| %Chg | N/A since 03/21/25 | -10.58% since 03/03/25 | -28.28% since 03/03/25 | ||
| Low | 0.0207 on 04/02/25 | 1.5500 on 04/03/25 | 1.0563 on 03/31/25 | ||
| High | 0.1000 on 03/21/25 | 1.9900 on 03/06/25 | 1.7600 on 03/17/25 | ||
| 3-Month | |||||
| %Chg | N/A since 03/21/25 | -62.86% since 01/03/25 | -87.38% since 01/03/25 | ||
| Low | 0.0207 on 04/02/25 | 1.5500 on 04/03/25 | 1.0563 on 03/31/25 | ||
| High | 0.1000 on 03/21/25 | 9.8000 on 01/24/25 | 12.5760 on 01/07/25 | ||
| 6-Month | |||||
| %Chg | N/A since 03/21/25 | -88.95% since 10/03/24 | -97.05% since 10/03/24 | ||
| Low | 0.0207 on 04/02/25 | 1.5500 on 04/03/25 | 1.0563 on 03/31/25 | ||
| High | 0.1000 on 03/21/25 | 15.6685 on 10/04/24 | 47.3280 on 10/18/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,650 | 1,983 | 1,643 | ||
| Shares Outstanding, K | 26,832 | 1,173 | 1,393 | ||
| Annual Sales | 9,940,000 | 70,000 | 3,787 | ||
| Annual Net Income | -164,570,000 | -22,130,000 | -27,260,000 | ||
| Last Quarter Sales | 0 | 3,020,000 | 20,000 | ||
| Last Quarter Net Income | -6,400,000 | -1,940,000 | -11,050,000 | ||
| 60-Month Beta | 1.31 | -0.25 | 1.20 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.68 on 10/31/24 | -0.20 on 10/31/24 | -8.80 on 11/12/24 | ||
| Latest Earnings Date | 03/26/25 | 05/27/25 | 05/21/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||